Embecta Corp. (EMBC)
5.765
-0.16
(-2.78%)
USD |
NASDAQ |
Sep 29, 16:00
5.765
0.00 (0.00%)
After-Hours: 20:00
Embecta Enterprise Value : 1.619B for Sept. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 28, 2026 | 1.619B |
| September 25, 2026 | 1.618B |
| September 24, 2026 | 1.602B |
| September 23, 2026 | 1.600B |
| September 22, 2026 | 1.600B |
| September 21, 2026 | 1.584B |
| September 18, 2026 | 1.583B |
| September 17, 2026 | 1.578B |
| September 16, 2026 | 1.574B |
| September 15, 2026 | 1.572B |
| September 14, 2026 | 1.580B |
| September 11, 2026 | 1.563B |
| September 10, 2026 | 1.561B |
| September 09, 2026 | 1.574B |
| September 08, 2026 | 1.598B |
| September 04, 2026 | 1.612B |
| September 03, 2026 | 1.606B |
| September 02, 2026 | 1.606B |
| September 01, 2026 | 1.581B |
| August 31, 2026 | 1.575B |
| August 28, 2026 | 1.570B |
| August 27, 2026 | 1.565B |
| August 26, 2026 | 1.565B |
| August 25, 2026 | 1.568B |
| August 24, 2026 | 1.566B |
| Date | Value |
|---|---|
| August 21, 2026 | 1.580B |
| August 20, 2026 | 1.593B |
| August 19, 2026 | 1.591B |
| August 18, 2026 | 1.572B |
| August 17, 2026 | 1.574B |
| August 14, 2026 | 1.572B |
| August 13, 2026 | 1.573B |
| August 12, 2026 | 1.553B |
| August 11, 2026 | 1.560B |
| August 10, 2026 | 1.566B |
| August 07, 2026 | 1.534B |
| August 06, 2026 | 1.482B |
| August 05, 2026 | 1.486B |
| August 04, 2026 | 1.500B |
| August 03, 2026 | 1.494B |
| July 31, 2026 | 1.490B |
| July 30, 2026 | 1.491B |
| July 29, 2026 | 1.492B |
| July 28, 2026 | 1.487B |
| July 27, 2026 | 1.478B |
| July 24, 2026 | 1.470B |
| July 23, 2026 | 1.468B |
| July 22, 2026 | 1.468B |
| July 21, 2026 | 1.474B |
| July 20, 2026 | 1.478B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Artivion, Inc. | 1.448B |
| Abbott Laboratories | 202.39B |
| AngioDynamics, Inc. | 605.12M |
| Alphatec Holdings, Inc. | 2.043B |
| AtriCure, Inc. | 2.877B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 21.10M |
| Revenue (Quarterly) | 271.70M |
| Total Expenses (Quarterly) | 250.60M |
| EPS Diluted (Quarterly) | 0.3606 |
| Gross Profit Margin (Quarterly) | 55.47% |
| Profit Margin (Quarterly) | 7.77% |
| Earnings Yield | 25.74% |
| Operating Earnings Yield | 79.01% |
| Normalized Earnings Yield | 37.12 |